Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Cyclophosphamide → AC regimen
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Cyclophosphamide | HCID 2907 | — |
| 반응물 | Doxorubicin | HCID 31703 | — |
| 반응물 | Doxorubicin Hydrochloride | HCID 443939 | — |
| 용매 | Chloroform | HCID 6212 | — |
| 생성물 | AC regimen | HCID 56841756 | — |
반응 단계
To a dark orange solution of Doxorubicin (0.036 g), prepared from Doxorubicin hydrochloride as described in the previous experiment, in chloroform (100 ml) were added while stirring at 50° PLA (4.048 g), cis-Pta2Cl2 (0.495 g) and cyclophosphamide (0.381 g in 40 ml dichloromethane). The mixture was transferred to a 500 ml ball mill jar about one-third filled with pebbles, rotated overnight and worked up as reported in Example 1 to give two samples of average particle sizes of 250-425μ and 150-250μ.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US04419340 |
| 출처 데이터셋 | uspto-grants-1983_12 |
| ORD ID | ord-0ecf59725b2b46b29e17cb5bd3d85d29 |
| 출처 메모 | uspto-grants-1983_12 |